Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R et al (2013) Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer 13:225. https://doi.org/10.1186/1471-2407-13-225

Article  PubMed  PubMed Central  Google Scholar 

O’Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the carolina breast cancer study. Clin Cancer Res 16:6100–6110. https://doi.org/10.1158/1078-0432.CCR-10-1533

Article  PubMed  PubMed Central  Google Scholar 

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong Y-N, Edge SB et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254–2261. https://doi.org/10.1200/JCO.2014.57.1349

Article  PubMed  PubMed Central  Google Scholar 

Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET (2024) Racial differences in breast cancer survival between black and white women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. https://doi.org/10.1200/JCO.23.02311

Article  PubMed  Google Scholar 

D’Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA (2015) Race-associated biological differences among luminal a breast tumors. Breast Cancer Res Treat 152:437–448. https://doi.org/10.1007/s10549-015-3474-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J et al (2017) Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas. JAMA Oncol 3:1654–1662. https://doi.org/10.1001/jamaoncol.2017.0595

Article  PubMed  PubMed Central  Google Scholar 

Purrington KS, Gorski D, Simon MS, Hastert TA, Kim S, Rosati R et al (2020) Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers. Breast Cancer Res Treat 181:145–154. https://doi.org/10.1007/s10549-020-05607-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benefield HC, Allott EH, Reeder-Hayes KE, Perou CM, Carey LA, Geradts J et al (2020) Borderline estrogen receptor-positive breast cancers in black and white women. J Natl Cancer Inst 112:728–736. https://doi.org/10.1093/jnci/djz206

Article  PubMed  CAS  Google Scholar 

Keim-Malpass J, Doede A, Camacho F, Kennedy C, Showalter SL (2018) Impact of patient health literacy on surgical treatment of breast cancer. Breast J 24:633–636. https://doi.org/10.1111/tbj.13011

Article  PubMed  Google Scholar 

Lin CM, Jaswal J, Vandenberg T, Tuck A, Brackstone M (2013) Weakly hormone receptor-positive breast cancer and use of adjuvant hormonal therapy. Curr Oncol 20:e612-613. https://doi.org/10.3747/co.20.1598

Article  PubMed  PubMed Central  Google Scholar 

Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529–537. https://doi.org/10.1007/s10549-010-1132-4

Article  PubMed  CAS  Google Scholar 

Wigertz A, Ahlgren J, Holmqvist M, Fornander T, Adolfsson J, Lindman H et al (2012) Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Breast Cancer Res Treat 133:367–373. https://doi.org/10.1007/s10549-012-1961-4

Article  PubMed  CAS  Google Scholar 

Hagen KB, Aas T, Kvaløy JT, Søiland H, Lind R (2019) Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: a 5-year prospective study. Breast 44:52–58. https://doi.org/10.1016/j.breast.2019.01.003

Article  PubMed  Google Scholar 

Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N (2022) Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast 62:22–35. https://doi.org/10.1016/j.breast.2022.01.012

Article  PubMed  PubMed Central  Google Scholar 

Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Kim B, Pillai A et al (2015) Adherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand? Breast 24:62–67. https://doi.org/10.1016/j.breast.2014.11.011

Article  PubMed  Google Scholar 

Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG (2015) Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health 24:403–408. https://doi.org/10.1089/jwh.2014.4982

Article  Google Scholar 

Sheppard VB, He J, Sutton A, Cromwell L, Adunlin G, Salgado TM et al (2019) Adherence to adjuvant endocrine therapy in insured black and white breast cancer survivors: exploring adherence measures in patient data. J Manag Care Spec Pharm 25(5):578–586. https://doi.org/10.18553/jmcp.2019.25.5.578

Article  PubMed  Google Scholar 

Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI et al (2012) Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 131:607–617. https://doi.org/10.1007/s10549-011-1762-1

Article  PubMed  CAS  Google Scholar 

Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32:2255–2269. https://doi.org/10.1200/JCO.2013.54.2258

Article  PubMed  PubMed Central  Google Scholar 

Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91:243–248. https://doi.org/10.1007/s10549-005-0324-9

Article  PubMed  Google Scholar 

Muss HB, Hunter CP, Wesley M, Correa P, Chen VW, Greenberg RS et al (1992) Treatment plans for black and white women with stage II node-positive breast cancer: the national cancer institute black/white cancer survival study experience. Cancer 70:2460–2467

Article  PubMed  CAS  Google Scholar 

Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496. https://doi.org/10.1093/jnci/94.7.490

Article  PubMed  Google Scholar 

Cykert S, Dilworth-Anderson P, Monroe MH, Walker P, McGuire FR, Corbie-Smith G et al (2010) Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303:2368–2376. https://doi.org/10.1001/jama.2010.793

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL (2004) Primary care physicians who treat blacks and whites. N Engl J Med 351:575–584. https://doi.org/10.1056/NEJMsa040609

Article  PubMed  CAS  Google Scholar 

Rogers SO, Ray WA, Smalley WE (2004) A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control 15:193–199. https://doi.org/10.1023/B:CACO.0000019511.67989.09

Article  PubMed  Google Scholar 

Silvestri GA, Handy J, Lackland D, Corley E, Reed CE (1998) Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 114:675–680. https://doi.org/10.1378/chest.114.3.675

Article  PubMed  CAS  Google Scholar 

Morris AM, Billingsley KG, Baxter NN, Baldwin L-M (2004) Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg 139:151–155. https://doi.org/10.1001/archsurg.139.2.151

Article  PubMed  Google Scholar 

Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK et al (2019) The detroit research on cancer survivors (ROCS) pilot study: a focus on outcomes after cancer in a racially diverse patient population. Cancer Epidemiol Biomarkers Prev 28:666–674. https://doi.org/10.1158/1055-9965.EPI-18-0123

Article